Myeloid malignancies after treatment for solid tumours.

Guru Murthy, Guru Subramanian

Myeloid malignancies after treatment for solid tumours. [electronic resource] - Best practice & research. Clinical haematology 03 2019 - 40-46 p. digital

Publication Type: Journal Article; Review

1532-1924

10.1016/j.beha.2019.02.012 doi


Chemotherapy, Adjuvant--adverse effects
Female
Granulocyte Colony-Stimulating Factor--therapeutic use
Hematologic Neoplasms--chemically induced
Humans
Male
Myeloproliferative Disorders--chemically induced
Neoplasms, Second Primary--metabolism
Platinum--adverse effects
Risk Factors
Topoisomerase II Inhibitors--adverse effects